Treatment of Acute Myeloid Leukemia with 20–30% Bone Marrow Blasts

The transition of patients with ≥20% <30% bone marrow (BM) blast from the FAB category of myelodysplasia to the family of acute myeloid leukemia (AML) according to the recent WHO classification has not resolved the argument as to whether the natural history and responsiveness to therapy of these...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maurillo, Luca, Buccisano, Francesco, Del Principe, Maria Ilaria, Sarlo, Chiara, Di Caprio, Luigi, Ditto, Concetta, Giannotti, Federica, Nasso, Daniela, Ceresoli, Eleonora, Postorino, Massimiliano, Refrigeri, Marco, Amadori, Sergio, Venditti, Adriano
Formato: Artigo
Idioma:Inglês
Publicado em: Università Cattolica del Sacro Cuore 2013
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684350/
https://ncbi.nlm.nih.gov/pubmed/23795270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2013.032
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados